Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET
Participants
Seth Blackley - Chief Executive Officer
John Johnson - Chief Financial Officer
Seth Frank - Vice President, Investor Relations
Conference Call Participants
Charles Rhyee - TD Cowen
Jailendra Singh - Truist Securities
Jeff Garro - Stephens
Stephanie Davis - Barclays
Ryan Daniels - William Blair
Matthew Gillmor - KeyBanc
Kyle Aikman - J.P. Morgan
Richard Close - Canaccord Genuity
Sean Dodge - RBC Capital Markets
Jessica Tassan - Piper Sandler
Kevin Caliendo - UBS
Daniel Grosslight - Citi
David Larsen - BTIG
Operator
Welcome to the Evolent Earnings Conference Call for the Third Quarter Ended September 30, 2024. As a reminder, this conference call is being recorded. Your hosts for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the rest of the week via the webcast on the company's website in the section titled Investor Relations.
I will now hand the call over to Seth Frank, Evolent's Vice President of Investor Relations.
Seth Frank
Thank you and good evening. This conference call will contain forward-looking statements under the U.S. Federal Laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our third quarter press release issued earlier today.
Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable